Risk factors of postinflammatory hyperpigmentation after laser in treatment of acquired bilateral nevus of Ota-like macules
10.3760/cma.j.issn.1671-0290.2021.05.017
- VernacularTitle:颧部褐青色斑激光治疗后炎症性色素沉着的危险因素分析
- Author:
Shaoyin MA
1
;
Yeqing GONG
;
Wenjun ZHANG
;
Peisi LI
;
Yueming LI
;
Shiqi HE
;
Boyi WANG
;
Huilan ZHU
Author Information
1. 广州市皮肤病防治所皮肤激光理疗科 510095
- Keywords:
Facial dermatoses;
Lasers;
Acquired bilateral nevus of Ota-like macules;
Postinflammatory pigmentation;
Risk factors
- From:
Chinese Journal of Medical Aesthetics and Cosmetology
2021;27(5):424-427
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the risk factors of postinflammatory hyperpigmentation (PIH) after laser in the treatment of acquired bilateral nevus of Ota-like macules (ABNOM).Methods:A retrospective study was conducted to follow up 120 patients with acquired bilateral nevus of Ota-like macules in the Department of Laser and Physiotherapy, Guangzhou Institute of Dermatology between January 2011 and December 2018, which accepted 1064-nm Q-switched neodymium: yttrium-aluminum-garnet laser treatment. The difference was analyzed between different age, sex, clinical classification, Fitzpatrick skin classification, ABNOM with melasma and postinflammatory pigmentation after laser treatment. Logistic regression was used to analyze the risk factors of postinflammatory hyperpigmentation after 1064-nm Q-switched neodymium: yttrium-aluminum-garnet laser treatment of acquired bilateral nevus of Ota-like macules.Results:Fifty-three ABNOM patients (44.17%) developed PIH after laser treatment. Univariate analysis showed that age, clinical classification, Fitzpatrick skin classification and the patients with both ABNOM and melasma all affected the occurrence of PIH after laser in the treatment of ABNOM, and the difference was statistically significant ( P<0.01). Logistic regression showed that older age, more severe clinical classification and the presence of ABNOM with melasma were the risk factors of PIH after treatment of ABNOM. Conclusions:ABNOM patients should be treated as early as possible. The risk of inducing PIH is great after laser treatment in patients with more severe clinical classification and patients with both ABNOM and melasma.
